Release Date: 29/04/16 08:30 Summary: Quarterly Cashflow Report-AVB.AX Price Sensitive: Yes Download Document 137.63KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%